Literature DB >> 12910604

[Visceral leishmaniasis].

Jerzy Stefaniak1, Małgorzata Paul, Elzbieta Kacprzak, Barbara Skoryna-Karcz.   

Abstract

Leishmanioses are widespread in 88 countries of the tropical and subtropical zone, including regions of the Mediterranean Sea basin of Southern Europe. Actually, approximately 350 million of people live in Leishmania endemic areas and about 12 million of individuals are infected. Visceral leishmaniosis (kala-azar disease, tropical splenomegaly) is caused by at least 3 species of Leishmania protozoa: L. donovani, L. infantum and L. chagasi. The incidence of the disease is estimated at 500,000 new cases annually. The infection is transmitted by Phlebotomus or Lutzomyia mosquitos bites, in which intestines forms invasive to humans are developed. Leishmania spp. have a predilection to the reticulo-histiocytary system cells, leading to their proliferation and disruption, and after spreading to the circulation they invade spleen, liver and bone marrow. Visceral leishmaniosis should be suspected in travelers returning from tropical and subtropical areas with signs of splenomegaly and twice temperature spikes in a day. We reported a case of the kala-azar disease in the 22 year-old Polish patient seasonally working in Italy. The clinical picture was expressed by two daily pikes of fever proceeded by chills, excessive sweat, hepatosplenomegaly, lymphadenopathy, general weakness, abdominal pain and nausea. The Leishmania infection was complicated by candidiosis. Laboratory tests showed anaemia, thrombocytopenia, leucopenia, hypergammaglobulinaemia and a suppression of immunological cellular response. The diagnosis was confirmed by a presence of amastigota forms in macrophages of the bone marrow aspirate and a detection of specific antibodies to L. infantum by Westernblotting. The patient was successfully treated with Glucantime.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12910604

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  3 in total

1.  Scientometric analysis of the world-wide research efforts concerning Leishmaniasis.

Authors:  K Al-Mutawakel; C Scutaru; A Shami; M Sakr; D A Groneberg; D Quarcoo
Journal:  Parasit Vectors       Date:  2010-03-04       Impact factor: 3.876

2.  Host-parasite Responses Outcome Regulate the Expression of Antimicrobial Peptide Genes in the Skin of BALB/c and C57BL/6 Murine Strains Following Leishmania major MRHO/IR/75/ER Infection.

Authors:  Hamid Daneshvar; Amir Tavakoli Kareshk; Iraj Sharifi; Alireza Keyhani; Razieh Tavakoli Oliaee; Arash Asadi
Journal:  Iran J Parasitol       Date:  2018 Oct-Dec       Impact factor: 1.012

Review 3.  Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.

Authors:  Rafael Rocha; André Pereira; Carla Maia
Journal:  Pathogens       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.